18: Could This Simple Blood Test Revolutionize Early Cancer Detection?
Jul 24, 2023•52 min
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
Buck talks with GRAIL President Josh Ofman, MD, MSHS, about their groundbreaking Multi-cancer early detection (MCED) technology and it's promise as a significant new tool in the war on cancer.
- 0:00:00 - Advancements in Cancer Detection Technology
- 0:00:35 - GRAIL Galleri test
- 0:02:11 - About Dr. Josh Ofman
- 0:05:14 - Cancer really is a disease of the genome
- 0:12:35 - Various guidelines for early detection of certain cancers
- 0:16:45 - Cancer Detection in Blood Biology
- 0:19:03 - Cell-Free DNA
- 0:23:38 - How many cancers is the GRAIL Galleri test able to detect?
- 0:27:10 - How accurate is the GRAIL Galleri test?
- 0:31:49 - Limitations of the GRAIL Galleri test
- 0:36:18 - Why would oncologists be against this test?
- 0:40:57 - What happens after one gets a a "cancer signal detected" result?
- 0:45:13 - GRAIL Galleri test's Impact on Cancer Screening
- 0:48:42 - The cost of the GRAIL Galleri test
For the best experience, listen in Metacast app for iOS or Android